Autolus Therapeutics Announces Publication in Molecular Therapy Nucleic Acids
26 avr. 2023 16h01 HE
|
Autolus Therapeutics plc
LONDON, April 26, 2023 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced...